Emerson’s Michalle Adkins and Ron Rossbach will host a webinar on reducing time to market for new therapies—a key opportunity for pharmaceutical and biopharmaceutical manufacturers. This webinar will take place on August 13 at 15:00 CET – Europe / 09:00 EDT.
For pharmaceutical and biopharmaceutical manufacturers, the Life Sciences.NOW webinar series includes eight interactive discussions on digital plant technologies and will provide direction and updates on key manufacturing operation initiatives to improve operational performance, deliver cost effective quality and regulatory compliance and accelerate the product development pipeline.
In a May 19 BioPharma Asia webinar, Continuous Manufacturing as a Default Platform for Oral Solid Drug Products, Emerson’s Bob Lenich will team up with Johnson and Johnson Senior Principal Engineer Lawrence De Belder to discuss the path to continuous manufacturing for these types of medicines.
Pharma 4.0 is an initiative based on Industry 4.0, begun out of the International Society for Pharmaceutical Engineering Germany/Austria/Switzerland (ISPE D/A/CH) organization, which lead to the formation of: …the ISPE Pharma 4.0 special interest group (SIG) in 2017....
Suppliers to the industry have been innovating to meet the single-use requirements of biotech manufacturers. Emerson’s Michalle Adkins pointed me to a recent award received for technology innovation for these single-use requirements.
Digital twins provide a simulation of the manufacturing or production process as well as the automation systems which control it. Depending on the level of fidelity of the process models, this digital twin can have many uses. I caught up with Emerson's Zuwei Jin who...
For pharmaceutical and biopharmaceutical manufacturers, scaling up production has typically meant large, 5000+ liter stainless steel bioreactors for the process. These require cleaning and sterilization between batches. Market demands are driving the need for more...
The Interphex conference for pharmaceutical and biotech manufacturers is underway this week in New York City. Emerson's Bob Lenich is presenting Big Data in Life Sciences Manufacturing. Bob opens citing one pharmaceutical manufacturer who generates 5000 data points...
The U.S. Food & Drug Administration (FDA) outlines the drug development process in five steps: Discovery and development Preclinical research Clinical trials FDA review FDA post-market safety monitoring I caught up with Emerson's Zuwei Jin whom you may recall from...
What is the 2019 outlook for research & development in the biotech industry? Pharmaceutical Processing magazine explores this question in an article, Outlook 2019: Tech, Data, and Biotech Boom. Emerson's Bob Lenich joined other suppliers to this industry to share...
Author: Jonathan Lustri Almost all Life Sciences manufacturing execution system (MES) projects include an interface to SAP, the enterprise resource management system. This interface is strategic in that this is how the business and production are tied together. It...
In a U.S. Food and Drug Administration's FDA Voice blog post, FDA Budget Matters: Investing in Advanced Domestic Manufacturing, FDA Commissioner Dr. Scott Gottlieb opened noting: Advanced manufacturing, which includes various technologies, such as continuous...
We invite you to follow us on Facebook, LinkedIn, Twitter and YouTube to keep up to date on all the latest news, events and innovations to help you take on and solve your toughest challenges.
Please do, Just link back to the post and send us a quick note so we can share your work. Thanks!
Our Global Community
The opinions expressed here are the personal opinions of the authors. Content published here is not read or approved by Emerson before it is posted and does not necessarily represent the views and opinions of Emerson.